| Literature DB >> 27816246 |
C G Todd1, K E Leslie1, S T Millman2, V Bielmann1, N G Anderson3, J M Sargeant4, T J DeVries5.
Abstract
The objectives of this study were to evaluate the effects of free-access acidified milk replacer feeding on the pre- and postweaning health of dairy and veal calves. Individually housed calves were systematically assigned at birth to 1 of 2 feeding programs: free-access feeding (ad libitum) of acidified milk replacer (ACD, n=249) or traditional restricted feeding (3L fed twice daily) of milk replacer (RES, n=249). Calves were fed milk replacer containing 24% crude protein and 18% fat. Acidified milk replacer was prepared to a target pH between 4.0 and 4.5 using formic acid. Calves were weaned off milk replacer at approximately 6wk of age. Weaning occurred over 5d, and during this weaning period, ACD calves had access to milk replacer for 12h/d and RES calves were offered only one feeding of milk replacer (3 L) daily. Calves were monitored daily for signs of disease. Fecal consistency scores were assigned each week from birth until weaning. A subset of calves was systematically selected for fecal sampling at 3 time points between 7 and 27d of age. Fecal samples were analyzed for enterotoxigenic Escherichia coli F5, Cryptosporidium parvum, rotavirus, and coronavirus. Hip width, hip height, body length, heart girth, and body weight were measured at birth and weaning. Postweaning body weight measurements were collected from the heifers at approximately 8mo of age. Postweaning body weight and carcass grading information was collected from the veal calves at slaughter once a live weight between 300 and 350kg had been achieved. The odds of ACD calves being treated for a preweaning disease event tended to be lower than that of the RES calves (1.2 vs. 5.2%, respectively). Preweaning mortality, postweaning disease treatment, and postweaning mortality did not differ between feeding treatments. The ACD feeding treatment supported greater preweaning average daily gain (0.59 vs. 0.43kg/d) and structural growth than RES feeding. Postweaning average daily gain and carcass characteristics were similar for ACD and RES calves. These results indicate that free-access acidified milk replacer feeding tended to support improved health, and greater body weight gain and structural growth during the preweaning period; these effects did not persist in the postweaning period. The growth advantage observed before weaning in the ACD calves likely disappeared due to the weaning methods used.Entities:
Keywords: acidified milk; calf; free-access milk feeding; growth; health
Mesh:
Year: 2016 PMID: 27816246 PMCID: PMC7094277 DOI: 10.3168/jds.2016-11401
Source DB: PubMed Journal: J Dairy Sci ISSN: 0022-0302 Impact factor: 4.034
Calving factors, colostrum management, serum total protein concentration, and structural characteristics at birth for Holstein calves assigned to free-access acidified (ACD)1 and restricted (RES)2 milk replacer feeding treatments
| Outcome | ACD treatment | RES treatment | |
|---|---|---|---|
| Number of calves, no. | 249 | 249 | |
| Calving location, % | 1.00 | ||
| Maternity area | 97.9 | 98.3 | |
| Dry cow free-stall | 2.1 | 1.7 | |
| Calving assistance categories, % | 0.78 | ||
| Unobserved | 73.8 | 74.5 | |
| Observed and required no assistance | 10.4 | 9.1 | |
| Required minimal assistance | 8.3 | 6.9 | |
| Dystocia | 7.5 | 9.5 | |
| Twin calves, % | 6.8 | 2.4 | 0.02 |
| Timing of first colostrum feeding, % | 0.74 | ||
| <2 h after birth | 75.8 | 77.3 | |
| ≥2 h and <4 h after birth | 20.2 | 20.0 | |
| >4 h after birth | 4.0 | 2.7 | |
| Colostrum source, % | 0.29 | ||
| Dam colostrum only | 2.1 | 3.8 | |
| Pooled colostrum | 97.9 | 96.2 | |
| Route of administration, % | 0.87 | ||
| Nurse bottle | 28.1 | 28.4 | |
| Esophageal feeder | 26.9 | 28.8 | |
| Nurse bottle and then esophageal feeder | 45.0 | 42.8 | |
| Number of colostrum feedings, | 2 (1, 2) | 2 (1, 2) | 0.86 |
| Total volume of colostrum fed, | 6.0 (2.0, 9.0) | 6.0 (2.0, 6.0) | 0.84 |
| Serum total protein concentration, | 5.6 (4.1, 7.8) | 5.7 (3.8,7.4) | 0.57 |
| Birth BW, | 42.1 (24.5, 55.3) | 42.1 (28.1, 56.7) | 0.99 |
| Birth hip width, | 20.7 (16.0, 24.0) | 20.8 (17.0, 25.0) | 0.55 |
| Birth hip height, | 78.2 (64.0, 90) | 78.4 (66.0, 89.0) | 0.53 |
| Birth body length, | 58.6 (47.0, 71.0) | 58.9 (51.0, 70.0) | 0.32 |
| Birth heart girth, | 78.9 (63.5, 88.9) | 78.9 (68.5, 87.6) | 0.98 |
Calves assigned to the ACD treatment had free access to milk replacer acidified to a target pH between 4.0 and 4.5.
Calves assigned to the RES treatment were fed 3 L of milk replacer twice daily.
Median (minimum, maximum) are presented.
Mean (minimum, maximum) are presented.
Measured between 1 and 8 d of age.
Measured at 0 d of age
Measured between 0 and 7 d of age.
Preweaning disease treatment, mortality, BW gain, and structural growth for Holstein calves assigned to free-access acidified (ACD)1 and restricted (RES)2 milk replacer feeding treatments
| Outcome | ACD treatment | RES treatment | |
|---|---|---|---|
| Number of calves, no. | 249 | 249 | |
| Preweaning disease treatment, | 3 (1.2) | 13 (5.2) | 0.07 |
| Preweaning mortality, | 7 (2.8) | 8 (3.2) | 0.79 |
| Preweaning growth | |||
| ADG, kg/d | 0.59 (0.55, 0.62) | 0.43 (0.39, 0.46) | <0.001 |
| BW at weaning, kg | 69.1 (67.0, 71.2) | 62.6 (60.6, 64.6) | <0.001 |
| Hip width growth, cm | 3.6 (3.3, 4.0) | 2.5 (2.2, 2.8) | <0.001 |
| Hip height growth, cm | 8.5 (7.6, 9.3) | 6.9 (6.1, 7.8) | <0.001 |
| Body length growth, cm | 12.2 (10.8, 13.6) | 9.6 (8.2, 11.0) | <0.001 |
| Heart girth growth, cm | 12.9 (11.9, 13.9) | 9.9 (8.9, 10.9) | <0.001 |
Calves assigned to the ACD treatment had free access to milk replacer acidified to a target pH between 4.0 and 4.5.
Calves assigned to the RES treatment were fed 3 L of milk replacer twice daily.
Treated for at least one disease event between birth and weaning.
Died before being weaned off milk.
Least squares means (95% CI) are presented.
Fecal consistency and shedding of enteropathogens for Holstein calves assigned to free-access acidified (ACD)1 and restricted (RES)2 milk replacer feeding treatments
| Outcome | ACD treatment | RES treatment | |
|---|---|---|---|
| Number of calves, | 249 | 249 | |
| Fecal consistency | |||
| Wk 1 visit | 1.0 (0.8, 1.1) | 1.0 (0.9, 1.1) | 1.00 |
| Wk 2 visit | 1.5 (1.4, 1.7) | 1.4 (1.3, 1.5) | 0.89 |
| Wk 3 visit | 1.4 (1.3, 1.5) | 1.3 (1.2, 1.4) | 0.95 |
| Wk 4 visit | 1.0 (0.9, 1.1) | 0.8 (0.7, 0.9) | 0.16 |
| Wk 5 visit | 0.8 (0.7, 0.9) | 0.4 (0.3, 0.5) | <0.001 |
| Wk 6 visit | 0.5 (0.4, 0.6) | 0.3 (0.1, 0.4) | 0.09 |
| Number of calves sampled, no. | 119 | 120 | |
| Number of fecal samples collected, | 357 | 360 | |
| Shedding of enteropathogens, % | |||
| | 27.9 | 22.2 | 0.09 |
| Rotavirus | 17.9 | 16.3 | 0.58 |
| Coronavirus | 6.4 | 8.0 | 0.42 |
| | 0 | 0 | 1.00 |
Calves assigned to the ACD treatment had free access to milk replacer acidified to a target pH between 4.0 and 4.5.
Calves assigned to the RES treatment were fed 3 L of milk replacer twice daily.
Calves were assigned a fecal consistency for 6 wk consecutively.
Fecal consistency was assessed on a 4-point scale: 0 = normal, 1 = semi-formed and pasty, 2 = loose consistency, 3 = watery consistency.
Least squares means (95% CI) are presented.
P-values: treatment <0.001, wk <0.001, and treatment × wk = 0.001.
A total of 3 fecal samples were collected from 119 ACD calves and 120 RES calves.
Postweaning disease treatment, mortality, and growth for Holstein replacement heifers assigned to free-access acidified (ACD)1 and restricted (RES)2 milk replacer feeding treatments
| Outcome | ACD treatment | RES treatment | |
|---|---|---|---|
| Number of calves, no. | 113 | 115 | |
| Postweaning disease treatment, | 25 (22.1) | 24 (20.9) | 0.80 |
| Postweaning mortality, | 6 (5.3) | 7 (6.1) | 0.80 |
| Postweaning growth | |||
| ADG for weaning to follow-up, kg/d | 0.99 (0.96, 1.02) | 1.00 (0.97, 1.03) | 0.58 |
| BW at follow-up, kg | 281.2 (254.9, 307.6) | 277.4 (251.0, 303.8) | 0.33 |
Calves assigned to the ACD treatment had free access to milk replacer acidified to a target pH between 4.0 and 4.5.
Calves assigned to the RES treatment were fed 3 L of milk replacer twice daily.
Treated for at least one disease event between weaning and follow-up.
Died between weaning and follow-up.
Least squares means (95% CI) are presented.
Postweaning disease treatment, mortality, and growth for Holstein veal calves assigned to free-access acidified (ACD)1 and restricted (RES)2 milk replacer feeding treatments
| Outcome | ACD treatment | RES treatment | |
|---|---|---|---|
| Number of calves, no. | 129 | 126 | |
| Postweaning disease treatment, | 47 (36.4) | 37 (29.4) | 0.18 |
| Postweaning mortality, | 13 (10.1) | 16 (12.7) | 0.50 |
| Postweaning growth | |||
| ADG from weaning to slaughter, kg/d | 1.33 (1.29, 1.38) | 1.37 (1.32, 1.41) | 0.13 |
| Live weight at slaughter, kg | 323.8 (315.8, 331.9) | 324.8 (316.6, 332.9) | 0.66 |
Calves assigned to the ACD treatment had free access to milk replacer acidified to a target pH between 4.0 and 4.5.
Calves assigned to the RES treatment were fed 3 L of milk replacer twice daily.
Treated for at least one disease event between weaning and slaughter.
Died between weaning and slaughter.
Least squares means (95% CI) are presented.